TrialJournal of general internal medicine2019

Associations Between Polypharmacy, Symptom Burden, and Quality of Life in Patients with Advanced, Life-Limiting Illness.

Yael Schenker et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.